Monday, November 21, 2011

New Hampshire EBITDA and Pharmacy Acquisitions

By Brad MacLiver
Authorship and profile at Google


EBITDA is an acronym that stands for: Earnings before interest, taxes, depreciation, and amortization. It is often utilized to measure the value of some businesses as well as used in the comparison of similar companies.
       
EBITDA generally makes it easier to evaluate various companies and to compare them against industry averages by removing the non-core and irregular operating costs like interest, which varies depending on the management’s choice of financing, as well as taxes, which fluctuates depending on acquisitions or losses from prior years.  Arbitrary factors of depreciation and amortization also effect EBITDA.

The formula for EBITDA can be used as a guideline when valuing larger companies or comparing the profitability of large similar companies in the same industry.

In order to use EBITDA effectively, these larger companies need to possess significant assets, have heavy amortization schedules, or have substantial amounts of debt. Considering independent New Hampshire pharmacies don’t meet that criteria, this formula is not a very useful measuring tool as the sole means for valuing pharmacies for acquisition purposes.

The Formula To Calculate EBITDA:
1) Calculate net income by obtaining total income and subtract total expenses.
2) Determine the total amount of taxes paid to federal, state, and local governments.
3) Compute interest fees paid to companies or individuals for the use of credit, or capital.
4) Establish the cost of depreciation (the expense recorded to allocate a tangible asset's cost over its useful life).
5) Determine the cost of amortization (the expense for consumption of the value of intangible assets, such as goodwill, patents, and copyrights, over a specific period of time, or the asset's expected life.
6) Add #1 through #5.

EBITDA calculation example:

1) Net Income            1,200
2) + Taxes paid            350
3) + Interest Expenses     220
4) + Depreciation          110
5) + Amortization           60
6) = EBITDA              1,940

Factors of EBITDA to watch out for:
1. It can be misleading number when it is confused with cash flow.
2. It can make even completely unprofitable firms appear to be financially healthy.
3. Numbers are easy to manipulate.
4. It can overlook cash requirements for growth in accounts receivable.
5. It can miss cash requirements for growth in inventories.
6. It is not factual when valuing small companies.
7. It is not effective for companies with few assets, small amounts of debt, or low depreciation or amortization schedules.

As a means of estimating, EBITDA has been used to gauge cash flow in leveraged buyouts to estimate if companies could service their debt. Factoring out interest, taxes, depreciation, and amortization can allow an unprofitable business to appear financially healthy. This method of valuation was used extensively during the dotcom era to value unprofitable businesses, with few assets, little earnings, and the results from that method caused many to go bust. This was a blaring example of misapplying EBITDA.

Knowledgeable pharmacy valuation experts performing New Hampshire pharmacy business valuations will use EBITDA in pharmacy valuations, but only as part of a larger formula when computing values for specialty pharmacies in NH especially those who have a niche in HIV, disease management, long term care, etc. However, EBITDA should not be used as part of the usual formula for standard retail pharmacy valuations used in acquisitions.

The EBITDA number for a specific existing New Hampshire pharmacy is important, for the most part, when the existing ownership is establishing their store value for the purpose of a line of credit, borrowing, creating a Trust, stock values, etc., but EBITDA does not have the same importance when selling a pharmacy in NH. This is due to the fact the buyer will not have the same expenses as the seller.

Buyers may not have the same tax base, interest expense, or the same depreciation schedule, thus it is important that the buyer calculate an estimated EBITDA that is specific to their operating model, business systems, buying power, cost of operations, etc., not the sellers. It should also be noted that EBITDA assumes that the buyer will acquire all of the assets, working capital, accounts receivable, and liabilities. Those assumptions do not hold true regarding an acquisition of a New Hampshire pharmacy. Instead of the EBITDA number, pharmacy buyers should be focusing on sales, gross profit, cash flow, and customer mix.

************************